
    
      A Phase I/Ib, Open-Label, Multicentre Study to Assess the Safety, Tolerability,
      Pharmacokinetics and Preliminary Anti-tumour Activity of AZD9150 in Patients with
      Advanced/Metastatic Hepatocellular Carcinoma.
    
  